日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors

Zilovertamab Vedotin治疗转移性实体瘤患者的II期研究

Meric-Bernstam, Funda; Gutierrez, Martin; Sanz-Garcia, Enrique; Villa, Diego; Zhang, Jun; Friedmann, Jennifer; Yan, Fengting; Socinski, Mark A; Sarantopoulos, John; Raez, Luis E; Chu, Quincy S; Chénard-Poirier, Maxime; Chatterjee, Manash S; Ren, Hong; Liu, Qi; Levine, Douglas A; Jhaveri, Komal L

Leveraging model-informed approaches for drug discovery and development in the cardiovascular space

利用模型指导的方法进行心血管领域的药物发现和开发

Dockendorf, Marissa F; Vargo, Ryan C; Gheyas, Ferdous; Chain, Anne S Y; Chatterjee, Manash S; Wenning, Larissa A

Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target

凝血因子 IXa 作为新型治疗靶点的临床前和转化评估

Wendy Ankrom, Harold B Wood, Jiayi Xu, Wayne Geissler, Tom Bateman, Manash S Chatterjee, Kung-I Feng, Joseph M Metzger, Walter R Strapps, Marija Tadin-Strapps, Dietmar Seiffert, Patrick Andre

Multiscale prediction of patient-specific platelet function under flow

流动状态下患者特异性血小板功能的多尺度预测

Matthew H Flamm, Thomas V Colace, Manash S Chatterjee, Huiyan Jing, Songtao Zhou, Daniel Jaeger, Lawrence F Brass, Talid Sinno, Scott L Diamond

Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli

成对激动剂扫描预测细胞对组合刺激的信号传导反应

Chatterjee, Manash S; Purvis, Jeremy E; Brass, Lawrence F; Diamond, Scott L

Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood

凝血启动的系统生物学:静息和激活状态下人血中凝血酶生成的动力学

Chatterjee, Manash S; Denney, William S; Jing, Huiyan; Diamond, Scott L

A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation

血小板磷脂酰肌醇和钙调节在稳态和P2Y1激活过程中的分子信号模型

Purvis, Jeremy E; Chatterjee, Manash S; Brass, Lawrence F; Diamond, Scott L

Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow

确定在静脉和动脉剪切速率下触发凝血的表面组织因子阈值:扩增 100 fM 循环组织因子需要流动

Uzoma M Okorie, William S Denney, Manash S Chatterjee, Keith B Neeves, Scott L Diamond